Orchestra BioMed Holdings, Inc.

OBIO

Orchestra BioMed Holdings, Inc.

OBIO

Insider Sentiment (TTM):

Last Purchase:2026-06-01Last Sale:2026-06-01Shares Purchased (TTM):55,636Shares Sold (TTM):15,032

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:23,023,072Shares Outstanding:62,721,869Institutional Ownership Pct.:36.71%

Earnings Market Reaction:

Filing Date:2026-08-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	20	28	35	42	19	18	22	26	24	23	31	19
Marketable Securities Current	89	66	72	54	15	32	45	41	41	52	57	89
Other Short Term Investments	-	-	-	-	-	-	-	-	-	0	0	0
Accounts Receivable Net Current	0	0	0	0	0	0	0	0	0	0	0	0
Inventory Net	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense And Other Assets Current	1	1	1	2	2	2	2	1	1	1	1	1
Assets Current	111	96	108	98	36	52	69	69	66	76	89	110
Property Plant And Equipment Net	2	2	2	2	1	1	1	1	1	1	1	1
Operating Lease Right Of Use Asset	1	1	1	2	2	2	2	2	1	2	2	2
Other Investments	-	-	-	-	-	2	2	2	2	2	2	2
Equity Securities Without Readily Determinable Fai…	-	-	2	2	2	-	2	-	-	-	-	-
Assets	116	101	115	105	43	59	76	75	72	83	95	116
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	6	6	6	8	5	6	5	5	6	3	3	3
Accrued Liabilities Current	7	7	10	7	7	5	6	7	4	4	5	4
Operating Lease Liability Current	1	1	1	1	1	1	1	0	0	0	1	1
Deferred Revenue Current	-	-	-	5	4	4	4	4	4	3	3	4
Loans Payable Current	-	-	-	-	-	-	-	-	-	-	-	10
Liabilities Current	13	14	17	21	17	15	16	16	15	10	11	21
Deferred Revenue Noncurrent	-	-	-	9	10	11	11	11	13	14	15	14
Long Term Loans Payable	14	14	14	14	14	14	14	-	-	-	-	-
Embedded Derivative Fair Value Of Embedded Derivat…	2	3	3	-	-	-	-	-	-	-	-	-
Operating Lease Liability Noncurrent	1	1	1	1	1	2	2	1	1	1	1	1
Other Liabilities Noncurrent	0	0	0	0	0	0	0	-	-	-	-	0
Liabilities	86	50	51	61	43	42	43	29	28	25	27	37
Temporary Equity Carrying Amount Including Portion…	10	10	10	-	-	-	-	-	-	-	-	-
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	426	424	416	413	348	345	343	340	322	320	317	316
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	0	0	0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-407	-383	-363	-369	-348	-329	-310	-294	-278	-262	-249	-236
Stockholders Equity	19	41	54	44	0	17	33	46	44	57	68	80
Liabilities And Stockholders Equity	116	101	115	105	43	59	76	75	72	83	95	116
Temporary Equity Par Or Stated Value Per Share	0	0	0	-	-	-	0	-	-	-	-	-
Temporary Equity Shares Issued	0	0	0	-	-	-	0	-	-	-	-	-
Preferred Stock Shares Outstanding	-	0	0	0	0	0	0	0	0	0	0	0
Temporary Equity Shares Outstanding	0	0	0	-	-	-	0	-	-	-	-	-
Temporary Equity Liquidation Preference	20	20	20	-	-	-	-	-	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	-	-	-	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	340	340	340	340	340	340	340	340	340	340	340	340
Common Stock Shares Issued	60	59	57	56	39	38	38	38	36	36	36	36
Shares Outstanding	60	59	57	56	39	38	38	38	36	36	36	36

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-3.94%	3.20%	-1.97%	-	-	-	-	-	-	-	-	-
2025	24.91%	9.06%	-7.92%	1.10%	-0.37%	43.38%	16.40%	14.02%	-7.67%	-2.51%	-9.36%	-10.73%
2024	73.48%	75.65%	46.52%	-8.18%	-18.49%	-13.42%	-11.13%	2.30%	-7.42%	-35.05%	-36.45%	-29.67%
2023	-	-	-	-	-	-	31.62%	23.51%	17.72%	-12.54%	-1.79%	50.24%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	8.26	7.03	6.45	4.73	2.10	3.35	4.27	4.23	4.58	7.34	7.95	5.13
Quick Ratio	8.17	6.90	6.37	4.64	1.99	3.23	4.13	4.13	4.50	7.21	7.82	5.07
Working Capital	97.77M	82.52M	91.18M	77.11M	18.82M	36.41M	52.96M	52.34M	51.98M	66.01M	77.91M	88.72M
Leverage & Debt
Debt to Equity	4.47	1.21	0.96	1.40	144.17	2.50	1.31	0.63	0.64	0.44	0.40	0.46
Interest Coverage TTM	-15.00	-25.74	-35.00	-60.72	-43.46	-27.45	-19.16	-10.42	-10.11	-9.37	-9.08	-15.22
Debt Ratio	0.75	0.49	0.45	0.58	0.99	0.71	0.57	0.39	0.39	0.31	0.29	0.32
Efficiency & Turnover
Asset Turnover TTM	0.40	0.41	0.35	0.03	0.05	0.04	0.03	0.03	0.02	0.02	0.03	0.04
Days Sales Outstanding TTM	0.76	0.96	1.02	10.82	10.10	9.86	13.21	13.86	22.03	11.78	12.89	8.72
Receivables Turnover TTM	477.25	378.31	358.10	33.75	36.12	37.00	27.62	26.34	16.57	30.99	28.31	41.87
Per Share Metrics
Diluted EPS TTM	-0.93	-0.87	-1.10	-1.44	-1.82	-1.73	-1.66	-1.53	-1.55	-1.44	-1.48	-1.31
Free Cash Flow Per Share TTM	-0.84	-0.88	-1.04	-0.85	-1.12	-1.42	-1.38	-1.28	-1.25	-1.26	-1.39	-1.25
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	99.51%	99.46%	99.43%	93.01%	92.66%	92.58%	92.27%	92.71%	92.02%	92.06%	93.26%	94.67%
Operating Profit Margin TTM	-181.36%	-167.96%	-154.73%	-2,669.91%	-2,420.75%	-2,383.89%	-2,437.49%	-2,270.68%	-2,803.61%	-2,454.15%	-1,866.16%	-1,356.65%
Net Profit Margin TTM	-185.51%	-166.86%	-157.40%	-2,665.05%	-2,367.49%	-2,297.85%	-2,313.27%	-2,179.34%	-2,673.26%	-2,330.46%	-1,779.71%	-1,278.87%
Growth Metrics
Net Revenue Growth (1Y)	986.14%	1,033.89%	1,169.22%	6.46%	41.61%	30.23%	-4.42%	-26.49%	-52.15%	-42.16%	-21.88%	48.19%
Net Income Growth (1Y)	-14.89%	-17.66%	-13.64%	30.19%	25.41%	28.41%	24.23%	25.26%	66.29%	133.57%	190.66%	536.28%
EPS Growth (1Y)	-48.80%	-49.81%	-33.40%	-6.15%	16.94%	20.16%	12.10%	17.35%	60.78%	80.46%	31.12%	264.46%
Valuation Metrics
P/E TTM	-4.64	-4.88	-3.76	-1.72	-1.48	-2.47	-2.41	-3.35	-5.25	-3.65	-6.18	-6.67
P/B TTM	14.25	6.47	3.70	2.96	348.79	9.71	4.47	4.18	6.61	3.30	4.46	3.86
P/S TTM	8.61	8.15	5.92	45.93	34.95	56.70	55.83	73.05	140.34	85.09	109.91	85.34
Market Cap	275.35M	266.57M	198.15M	129.42M	102.89M	163.65M	147.28M	193.37M	291.77M	188.55M	303.35M	307.32M
Enterprise Value	254.88M	238.20M	163.46M	87.41M	84.14M	145.30M	125.02M	167.77M	268.06M	165.23M	272.79M	297.85M
Calculated Values
Free Cash Flow TTM	-53.48M	-55.23M	-49.61M	-44.22M	-43.13M	-54.45M	-50.85M	-48.18M	-44.71M	-44.92M	-46.21M	-44.03M
Net Debt	-20.47M	-28.37M	-34.69M	-42.01M	-18.75M	-18.35M	-22.26M	-25.61M	-23.71M	-23.32M	-30.56M	-9.48M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-01Purchase

Owner: Hochman, David P

Title: See Remarks

Shares: 5,000

Price/Share: $3.83

Value: $19,150.00

Shares Owned: 1,064,029

Relationship: Director,Officer

Ownership: Direct

2026-06-01Sale

Owner: Sherman, Darren

Title: See Remarks

Shares: 15,000

Price/Share: $3.87

Value: $58,050.00

Shares Owned: 1,184,327

Relationship: Director,Officer

Ownership: Direct

2026-05-18Purchase

Owner: Aryeh, Jason

Title: -

Shares: 665

Price/Share: $3.75

Value: $2,493.75

Shares Owned: 118,118

Relationship: Director

Ownership: Direct

2026-05-15Purchase

Owner: Hochman, David P

Title: See Remarks

Shares: 5,000

Price/Share: $3.77

Value: $18,850.00

Shares Owned: 1,059,029

Relationship: Director,Officer

Ownership: Direct

2026-05-15Purchase

Owner: Aryeh, Jason

Title: -

Shares: 8,971

Price/Share: $3.90

Value: $34,986.90

Shares Owned: 117,453

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-01	Hochman, David P	Director,Officer	See Remarks	Direct	Purchase	5,000	3.83	$19,150.00	1,064,029	4
2026-06-01	Sherman, Darren	Director,Officer	See Remarks	Direct	Sale	15,000	3.87	$58,050.00	1,184,327	4
2026-05-18	Aryeh, Jason	Director	-	Direct	Purchase	665	3.75	$2,493.75	118,118	4
2026-05-15	Hochman, David P	Director,Officer	See Remarks	Direct	Purchase	5,000	3.77	$18,850.00	1,059,029	4
2026-05-15	Aryeh, Jason	Director	-	Direct	Purchase	8,971	3.90	$34,986.90	117,453	4
2026-05-14	Fain, Eric S	Director	-	Indirect	Purchase	20,000	4.13	$82,600.00	91,709	4
2026-04-27	Rtw, Investments, Lp, Won…	TenPercentOwner	-	Indirect	Sale	32	4.13	$132.16	9,556,063	4
2026-03-13	Hochman, David P	Director,Officer	See Remarks	Direct	Purchase	10,000	4.29	$42,900.00	1,086,467	4
2025-11-14	Hochman, David P	Director,Officer	See Remarks	Direct	Purchase	5,000	4.07	$20,350.00	612,822	4
2025-09-19	Aryeh, Jason	Director	-	Direct	Purchase	1,000	2.45	$2,450.00	108,482	4
2025-08-25	Fain, Eric S	Director	-	Indirect	Purchase	5,760	2.61	$15,033.60	71,709	4
2025-08-25	Taylor, Andrew Lawrence	Officer	Chief Financial Officer	Direct	Purchase	2,000	2.55	$5,100.00	482,788	4
2025-08-25	Sherman, Darren	Director,Officer	See Remarks	Direct	Purchase	3,000	2.62	$7,860.00	926,837	4
2025-08-21	Hochman, David P	Director,Officer	See Remarks	Direct	Purchase	6,000	2.49	$14,940.00	651,460	4
2025-08-04	Hochman, David P	Director,Officer	See Remarks	Indirect	Purchase	20,000	2.75	$55,000.00	349,331	4
2025-08-01	Perceptive, Life Sciences…	TenPercentOwner	-	Indirect	Purchase	700,000	2.75	$1,925,000.00	5,292,556	4
2025-06-26	Fain, Eric S	Director	-	Indirect	Sale	2,683	3.05	$8,183.15	50,949	4
2025-04-30	Wong, Roderick, Rtw Inves…	TenPercentOwner	-	Indirect	Purchase	49,900	2.99	$149,201.00	8,306,063	4
2025-04-29	Rtw, Investments, Lp, Won…	TenPercentOwner	-	Indirect	Purchase	50,000	2.53	$126,500.00	8,256,163	4
2024-12-23	Hochman, David P	Director,Officer	See Remarks	Direct	Purchase	4,000	4.66	$18,640.00	579,498	4
2024-12-19	Taylor, Andrew Lawrence	Officer	Chief Financial Officer	Direct	Purchase	1,000	4.83	$4,830.00	344,960	4
2024-12-18	Hochman, David P	Director,Officer	See Remarks	Direct	Purchase	5,000	4.91	$24,550.00	575,498	4
2024-09-25	Hochman, David P	Director,Officer	See Remarks	Indirect	Purchase	7,500	4.76	$35,700.00	335,002	4
2024-09-10	Sherman, Darren	Director,Officer	See Remarks	Direct	Sale	6,904	5.31	$36,660.24	765,787	4
2024-09-10	Fain, Eric S	Director	-	Indirect	Sale	1,800	5.34	$9,612.00	41,210	4
2024-09-06	Sherman, Darren	Director,Officer	See Remarks	Direct	Sale	6,819	5.65	$38,527.35	779,495	4
2024-08-14	Hochman, David P	Director,Officer	See Remarks	Direct	Purchase	2,500	5.84	$14,600.00	567,998	4
2024-06-25	Hochman, David P	Director,Officer	See Remarks	Indirect	Purchase	1,000	6.95	$6,950.00	333,502	4
2024-05-30	Little, William Reed	Officer	See Remarks	Direct	Purchase	4,000	7.00	$28,000.00	307,859	4
2024-05-17	Hochman, David P	Director,Officer	See Remarks	Indirect	Purchase	3,000	5.15	$15,450.00	332,502	4/A
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

36.71%

Inst. Shares: 23,023,072

Shares Outstanding: 62,721,869

2025-12-31

44.59%

Inst. Shares: 21,291,542

Shares Outstanding: 47,747,078

2025-09-30

42.85%

Inst. Shares: 22,359,930

Shares Outstanding: 52,186,503

2025-06-30

45.79%

Inst. Shares: 17,579,638

Shares Outstanding: 38,392,716

2025-03-31

48.25%

Inst. Shares: 18,450,363

Shares Outstanding: 38,235,409

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	23,023,072	62,721,869	36.71%
2025-12-31	21,291,542	47,747,078	44.59%
2025-09-30	22,359,930	52,186,503	42.85%
2025-06-30	17,579,638	38,392,716	45.79%
2025-03-31	18,450,363	38,235,409	48.25%
2024-12-31	18,658,153	36,821,042	50.67%
2024-09-30	18,376,322	37,621,495	48.85%
2024-06-30	13,612,573	35,800,273	38.02%
2024-03-31	12,683,427	35,777,877	35.45%
2023-12-31	12,622,847	33,225,227	37.99%
2023-09-30	12,454,196	35,243,598	35.34%
2023-06-30	9,859,271	34,613,466	28.48%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Orchestra BioMed Holdings, Inc. (OBIO) — SEC Financial Statements & Analysis

Orchestra BioMed Holdings, Inc. (OBIO) is a surgical & medical instruments & apparatus company, incorporated in DE. Orchestra BioMed Holdings, Inc. trades on Nasdaq as: OBIO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Orchestra BioMed Holdings, Inc. reported a 986.14% year-over-year revenue growth, a Gross Profit Margin of 99.51% (TTM), a Debt-to-Equity ratio of 4.47x, a Price-to-Sales (P/S) ratio of 8.61x (TTM), a Price-to-Book (P/B) ratio of 14.25x (TTM), at a market cap of $275.35M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 986.14%
Gross Profit Margin TTM: 99.51%
Debt To Equity: 4.47x
P/S TTM: 8.61x
P/B TTM: 14.25x
Market Cap: $275.35M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Orchestra BioMed Holdings, Inc. in?

Orchestra BioMed Holdings, Inc. (OBIO) operates in the Surgical & Medical Instruments & Apparatus industry.

What is OBIO's market cap?

Orchestra BioMed Holdings, Inc. (OBIO) has a market capitalization of $275.35M as of 2026-06-30.

What exchange does OBIO trade on?

Orchestra BioMed Holdings, Inc. (OBIO) trades on the Nasdaq.

Where is Orchestra BioMed Holdings, Inc. incorporated?

Orchestra BioMed Holdings, Inc. is incorporated in DE.